All Stories

  1. The generalisability of randomised clinical trials: an interim external validity analysis of the ongoing SENOMAC trial in sentinel lymph node-positive breast cancer
  2. Breast-conserving surgery followed by whole-breast irradiation offers survival benefits over mastectomy without irradiation
  3. Risk of recurrence and death in patients with breast cancer after delayed deep inferior epigastric perforator flap reconstruction
  4. Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial
  5. Swedish prospective multicenter trial evaluating sentinel lymph node biopsy after neoadjuvant systemic therapy in clinically node-positive breast cancer
  6. Swedish prospective multicenter trial on the accuracy and clinical relevance of sentinel lymph node biopsy before neoadjuvant systemic therapy in breast cancer
  7. Impact of previous surgery on sentinel lymph node mapping: Hybrid SPECT/CT before and after a unilateral diagnostic breast excision
  8. National study of the impact of patient information and involvement in decision-making on immediate breast reconstruction rates
  9. Incidence of and risk factors for sentinel lymph node metastasis in patients with a postoperative diagnosis of ductal carcinomain situ
  10. Radiotherapy in implant-based immediate breast reconstruction: risk factors, surgical outcomes, and patient-reported outcome measures in a large Swedish multicenter cohort
  11. Authors' reply: Causes of false-negative sentinel node biopsy in patients with breast cancer (Br J Surg2013; 100: 775-783)
  12. High Prevalence of Human Cytomegalovirus Proteins and Nucleic Acids in Primary Breast Cancer and Metastatic Sentinel Lymph Nodes
  13. Causes of false-negative sentinel node biopsy in patients with breast cancer
  14. Tumor-dependent increase of serum amino acid levels in breast cancer patients has diagnostic potential and correlates with molecular tumor subtypes
  15. Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients
  16. Tumor-induced changes in the phenotype of blood-derived and tumor-associated T cells of early stage breast cancer patients
  17. Prediction of Non-Sentinel Lymph Node Status in Breast Cancer Patients with Sentinel Lymph Node Metastases: Evaluation of the Tenon Score
  18. Axillary recurrence rate 5 years after negative sentinel node biopsy for breast cancer
  19. Tumor-dependent down-regulation of the ζ-chain in T-cells is detectable in early breast cancer and correlates with immune cell function
  20. Breast Cancer Survival in Relation to the Metastatic Tumor Burden in Axillary Lymph Nodes
  21. Axillary Recurrence Rate After Negative Sentinel Node Biopsy in Breast Cancer
  22. Sentinel node biopsy for breast cancer larger than 3 cm in diameter